GMED · Globus Medical, Inc.
$81.41
-0.31% last session
End-of-day data · close of 2026-10-23
Market cap
$11B
Enterprise value
$10B
Trailing P/E
20.9
Forward P/E
15.1
Dividend yield
0.0%
Beta
0.96
Avg volume
1M
Employees
6K
Daily Change %
-0.31%
5 Days Change
6.45%
10 Days Change
7.00%
30 Days Change
10.41%
60 Days Change
-2.88%
Month to Day Change
9.74%
Year to Day Change
-6.47%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — GMED
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-01
Latest call per bank · past 12 months
RBC Capital
Outperform$85.00
+4.4% vs priceWells Fargo
Overweight$99.00
+21.6% vs priceUBS
Neutral$82.00
+0.7% vs priceBarclays
Overweight$123
+51.1% vs priceMorgan Stanley
Overweight$100
+22.8% vs priceBank of America
Buy$91.00
+11.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-01 | RBC Capital | Maintains | Outperform | $115 → $85.00 |
| 2026-08-07 | Wells Fargo | Maintains | Overweight | $103 → $99.00 |
| 2026-07-28 | UBS | Initiates | Neutral | $0.00 → $82.00 |
| 2026-07-16 | Truist Securities | Maintains | Buy | $115 → $100 |
| 2026-07-13 | RBC Capital | Maintains | Outperform | $120 → $115 |
| 2026-07-09 | BMO Capital | Initiates | Outperform | $0.00 → $94.00 |
| 2026-07-08 | Stifel | Maintains | Hold | $95.00 → $80.00 |
| 2026-06-15 | Piper Sandler | Maintains | Overweight | $115 → $100 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 63 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 4.2% above the 50-day MA ($78.15).
- bearish: Price vs 200-day MA: Trading 2.8% below the 200-day MA ($83.79).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.80) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($60.39) and high ($96.82).
GMED Price Chart
Loading chart for GMED…
Fundamentals
About Globus Medical, Inc.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
More in Medical Devices
ABT
Abbott Laboratories
$179B -16.2% YTD
MDT
Medtronic plc.
$122B 3.1% YTD
SYK
Stryker Corporation
$118B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$51B 5.7% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.8% YTD
DXCM
DexCom, Inc.
$29B 18.0% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 3.3% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.